RRM2 and cancer: As the catalytic subunit of RR, RRM2 is the rate-limiting enzyme for DNA synthesis and repair, and its expression level is associated with the sensitivity of cancer cells to chemotherapy drugs and endocrine therapy drugs [10,25,28].